BioMarin Pharmaceuticals Inc Stock Prediction
AI-powered sentiment analysis and prediction trends for BMRN, updated each market day.
BMRN AI Sentiment
AI sees no strong directional signal for BioMarin Pharmaceuticals Inc stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About BioMarin Pharmaceuticals Inc
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
Sector
Exchange
Market Cap
$10,827,805,111
Cap Tier
Employees
3,221
Headquarters
NOVATO, CA
Listed Since
July 23, 1999
Website
BMRN Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
BMRN Volatility
BioMarin Pharmaceuticals Inc has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
